FY23 Appendix 4E and Annual Report
Released
Released
Announcement PDF
Appendix 4E
Hearts and Minds Investments Limited (HM1)
ABN 61 628 753 220
Financial Report
Results for Announcement to the Market for the Year Ended 30 June 2023
Change
30 Jun 2023
30 Jun 2022
$’000
$’000
Total Net Investment Income
147%
57,581
(122,588)
Profit/(Loss) from ordinary activities after tax
135%
32,726
(94,837)
Other Comprehensive Income net of tax
124%
30,227
(124,752)
Total Comprehensive Income net of tax
129%
62,954
(219,589)
30 Jun 2023
$2.90
30 Jun 2022
$2.58
Net tax benefit/(liability) per ordinary share
$0.05
$0.23
Post-tax NTA per ordinary share
$2.95
$2.81
Net Tangible Assets (NTA) Per Ordinary Share
Pre-tax NTA per ordinary share
Dividends
In April 2023 HM1 paid its third annual dividend to shareholders. A fully franked dividend of 13.5 cents per
ordinary share was paid on 12 April 2023. The Board maintains a policy of paying fully franked dividends
to shareholders subject to sufficient cash reserves, available franking credits and prudent business practice.
Following shareholder feedback we have modified the dividend policy to increase the frequency of dividend
payments to twice yearly. The half-yearly dividend will be paid in April and October of each year. The first
half-yearly fully franked dividend of 7 cents per share will be paid in October 2023.
_____________________________________________
Hearts and Minds Investments Limited ACN 628 753 220
A: 12.04A, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 | W: HM1.com.au | E: ir@hm1.com.au | P: 1300 737 760 or +61 2 9290 9600
Appendix 4E
The Dividend Reinvestment Plan (DRP) will be in operation and participating shareholders can reinvest
their cash dividend in new HM1 shares at the DRP issue price. The DRP issue price will be based on the
market price of shares issued or acquired under the on market acquisition provisions of the DRP.
Dividend per ordinary share
Cents per
Ordinary share
Franking
%
7.0
100%
Dividend dates:
Ex-dividend date:
20 September 2023
Record date:
21 September 2023
DRP election date:
25 September 2023
Payment date:
19 October 2023
Brief Explanation of Results:
For the year ended 30 June 2023, the Company recorded a total comprehensive income after tax of $63.0
million (2022: total comprehensive loss after tax of $219.6 million). The result is driven by the investment
portfolio which increased on a pre-tax basis by 15.1% for the year ended 30 June 2023. The investment
performance benefited from a strong recovery in the market values of the Core Portfolio, partially offset by
net realised losses primarily from the previous year’s Conference Portfolio.
The net asset value of the Company increased 5.4% over the year from $641.1 million on 30 June 2022 to
$675.5 million as of 30 June 2023. Since the inception of the Company in November 2018 HM1 has
generated a compound annual pre-tax investment return of 8.8%. Further details of the performance of the
investment portfolio and the Company can be found in the Investment Committee Report.
In line with its philanthropic objective, HM1 provides financial support to leading Australian medical research
organisations to help the development of new medicines and treatments and drive a new generation of
medical research in Australia. HM1 and its participating fund managers forego any investment fees and
instead donate an amount equivalent to 1.5% of net tangible assets per annum to designated medical
research organisations. During the year ended 30 June 2023, HM1 paid $10.2 million to its designated
medical research organisations and provided for a further $5.7 million, bringing the total funding to medical
research to $49.8 million since inception. Further details on the results are included in the Annual Report.
This report is based on the Annual Report which has been audited by Pitcher Partners. The audit report is
included in the Annual Report which accompanies this Appendix 4E. All the documents comprise the
information required by Listing Rule 4.3A.
Annual General Meeting
HM1 advises that its Annual General Meeting will be held on or around Thursday, 30 November 2023. The
time and other details relating to the meeting will be advised in the Notice of Meeting to be sent to all
shareholders and released to ASX immediately after dispatch. In accordance with the ASX Listing Rules,
valid nominations for the position of director are required to be lodged at the registered office of the
Company by 5:00 pm (AEDT) on Monday, 2 October 2023.
_____________________________________________
Hearts and Minds Investments Limited ACN 628 753 220
A: 12.04A, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 | W: HM1.com.au | E: ir@hm1.com.au | P: 1300 737 760 or +61 2 9290 9600
Hearts and Minds
Investments Limited
Annual
Report
For the year ended
30 June 2023
ACN 628 753 220
Hearts and Minds Investments Limited
For the year ended 30 June 2023
Contents
Corporate Directory
1
Chairman and Chief Executive Officer’s Letter
3
Investment Committee Report
5
Medical Research Report
13
Directors’ Report to Shareholders
18
Auditor’s Independence Declaration
31
Financial Statements
Statement of Comprehensive Income
32
Statement of Financial Position
33
Statement of Changes in Equity
34
Statement of Cash Flows
35
Notes to the Financial Statements
36
Directors’ Declaration
61
Independent Auditor’s Review Report to the Shareholders
62
ASX Additional Information
66
Hearts and Minds Investments Limited
ACN 628 753 220
Corporate Directory
Corporate Directory
Directors
(Pro bono)
Christopher Cuffe AO
Lorraine Berends
Guy Fowler
Matthew Grounds AM
Michael Traill AM
Gary Weiss AM
Geoffrey Wilson AO
David Wright
Company Secretary
(Pro bono)
Tom Bloomfield
Investment Committee
(Pro bono)
Lorraine Berends
David Wright
Christopher Cuffe AO
Matthew Grounds AM
Brett Paton
Paul Rayson
Conference Fund Manager
Selection Committee
(Pro bono)
David Wright
Gary Weiss AM
Michael Walsh
Charlie Lanchester
Core Fund Managers
(Pro bono)
Caledonia (Private) Investments
Cooper Investors
Magellan Asset Management
Munro Partners
Regal Funds Management
TDM Growth Partners
Tribeca Investment Partners
2022 Conference Fund Managers
(Pro bono)
Auscap Asset Management
Claremont Global
Eminence Capital
FACT Capital
Firetrail Investments
Munro Partners
Registered Office
Boardroom Pty Limited
Level 8, 210 George Street
Sydney NSW 2000
Auditor
Pitcher Partners
Level 16, Tower 2 Darling Park
201 Sussex Street, NSW 2000
Telephone: (02) 9221 2099
Administrator
Citco Fund Services (Australia) Pty Limited
Level 22, 45 Clarence Street
Sydney NSW 2000
Telephone: (02) 9005 0400
1
Chairman and Independent Director
Independent Director
Independent Director
Independent Director
Independent Director
Independent Director
Independent Director
Independent Director
Chair
Perpetual
Regal Funds Management
Samuel Terry Asset Management
Tribeca Investment Partners
WaveStone Capital
Hearts and Minds Investments Limited
ACN 628 753 220
Corporate Directory (continued)
Share Registrar
Boardroom Pty Limited
Level 8, 210 George Street
Sydney NSW 2000
Telephone: (02) 9290 9600
Stock Exchange
Australian Securities Exchange
The home exchange is Sydney
ASX code: HM1 Ordinary Shares
2
Hearts and Minds Investments Limited
Chairman and Chief Executive Officer’s Letter
For the year ended 30 June 2023
Chairman and Chief Executive Officer’s Letter
Dear Shareholders,
On behalf of the Board and management we would like to thank you for your ongoing support of Hearts and Minds
Investments Limited (hereafter referred to as ‘HM1’ or the ‘Company’) and we are pleased to share the Annual Report
for the year ended 30 June 2023.
HM1 is a listed investment company that was established in 2018 with the combined objective of providing a
concentrated securities portfolio of the highest conviction ideas from respected fund managers, whilst also supporting
Australian medical research institutes. It was born out of the investment and philanthropic vision of the Sohn Hearts &
Minds Investment Leaders Conference.
We are pleased to report that, following the changes we made to the management of our investment portfolio over the
last year, investment performance is beginning to improve. These changes included:
We refined the selection process for Conference Fund Managers to provide greater diversification of fund manager
style and sector exposure. We also implemented a stock risk filter to avoid an over concentration of single risk
factors. These changes were implemented for the current Conference Portfolio.
In November 2022, we appointed two new Core Fund Managers, Munro Partners and Tribeca Investment Partners
to replace Paradice Investment Management at the end of their mandate term. Munro Partners is an investment
manager with a core focus on global growth equities. Munro Partners’ Founder and Chief Investment Officer, Nick
Griffin, has been a Conference Fund Manager to HM1 over the last 4 years and has achieved excellent returns for
HM1 in each year. Tribeca Investment Partners manages a suite of specialist strategies across equities, credit,
global natural resources and opportunistic mandates. Jun Bei Liu is the Portfolio Manager of Tribeca’s Alpha Plus
Fund. Since taking over the Alpha Plus Fund, she has doubled funds under management to over $1bn, making it
one of the largest long-short equity funds in the Australian market. Jun Bei has been a Conference Fund Manager
for 3 out of the last 4 years and has also achieved excellent returns in each year. Munro Partners’ and Tribeca
Investment Partners’ mandate as a Core Fund Manager to HM1 will be for an initial term of 3 years.
Also in November 2022, we amended the portfolio investment guidelines for the Core Portfolio to provide additional
flexibility to access the expertise, style and investment performance of our Core Fund Managers. The change
permits HM1 to gain exposure to the highest conviction strategies of our Core Fund Managers, whether via listed
or unlisted securities. The change is expected to provide both performance and diversification benefits whilst
retaining the essence of a high conviction portfolio. An investment in unlisted securities will be by exception only,
and only where such investment provides HM1 with a better method to gain exposure to a particular Core Fund
Manager’s expertise, style and investment performance. For clarity, HM1’s portfolio exposure will remain
predominantly listed equity exposures.
Following these changes, in January 2023 HM1 invested in two unlisted securities, Guzman Y Gomez Ltd and Rokt
Ltd, that are high conviction investments of TDM Growth Partners, one of our Core Fund Managers. HM1 also made
an investment in an unlisted managed fund operated by another Core Fund Manager, Regal Funds Management. In
both these cases, HM1 determined that the investments are appropriate and provide HM1 with a better form of exposure
to the expertise, style and investment performance of those Core Fund Managers. On 30 June 2023, these investments
represent in total 8.4% of HM1’s investment portfolio.
In March 2023, we announced the appointment of Charlie Lanchester as the new Chief Investment Officer for HM1.
Charlie is an accomplished fund manager and investor with over 30 years active funds management experience at
leading investment organisations. We are delighted to have someone of Charlie’s experience and calibre to select and
manage HM1’s suite of Core and Conference Fund Managers and oversee HM1’s investment portfolio.
Over the last year the Board has been very focussed on, and dissatisfied with, the discount at which the HM1 share
price is trading to its net tangible assets (NTA). In light of the share price discount, and following shareholder feedback,
the Board decided to modify the dividend policy to increase the frequency of dividend payments to twice yearly. The
half-yearly dividend will be paid in April and October of each year.
We believe that the changes we have made to the management of HM1’s investment portfolio will lead to a sustained
improvement in investment performance. We further believe that this, combined with our modified dividend policy and
improved insight and disclosure of our investment portfolio, will narrow the share price discount to NTA over time.
3
Hearts and Minds Investments Limited
Chairman and Chief Executive Officer’s Letter (continued)
For the year ended 30 June 2023
The HM1 investment portfolio increased on a pre-tax basis by 15.1% for the year ended 30 June 2023, recovering
some of the losses of the prior year. Since the inception of the Company in November 2018, HM1 has generated a
compound pre-tax investment return of 8.8% per annum. For the year ended 30 June 2023, HM1 recorded a total
comprehensive income after tax of $63.0 million (2022: total comprehensive loss after tax of $219.6 million). The result
was driven by a strong recovery in the market value of the Core Portfolio generating unrealised gains, partially offset
by realised losses from the previous year’s Conference Portfolio. Further details of the performance of the investment
portfolio can be found in the Investment Committee Report.
In April 2023, HM1 paid its third annual dividend to shareholders. A fully franked dividend of 13.5 cents per ordinary
share was paid on 13 April 2023. Our dividend reinvestment plan was operational and many shareholders reinvested
their dividend in HM1 shares at the prevailing market price. The Board aims to maintain a policy of paying fully franked
dividends to shareholders subject to sufficient cash reserves, available franking credits and prudent business practice.
As noted above we have modified the dividend policy to increase the frequency of dividend payments to twice yearly.
The first half-yearly dividend of 7 cents per share will be paid in October 2023.
In line with its philanthropic objective, HM1 provides financial contributions equivalent to 1.5% of NTA per annum to
leading Australian medical research organisations, to fund the development of new medicines and treatments and to
drive a new generation of medical research in Australia. This is effectively funded by HM1’s participating fund
managers, its Board of Directors and Committees and many of our service providers all working on a pro bono basis.
We sincerely thank everyone for their ongoing involvement and generosity.
During the year ended 30 June 2023, HM1 paid $10.2 million to its designated medical research organisations and
made provision for a further $5.7 million. These donated monies will be used by the medical research organisations to
fund important research into the prevention and treatment of chronic diseases and mental health disorders.
The current designated medical research organisations are Baker Heart and Diabetes Institute, University of Sydney
Brain and Mind Centre, Cerebral Palsy Alliance Research Foundation, The Florey, Kids Critical Care Research at The
Children’s Hospital at Westmead, Pain Management Research Institute, RPA Green Light Institute, Victor Chang
Cardiac Research Institute and WEHI. More information on the wonderful work of these organisations can be found in
the Medical Research Report.
Finally, we would also like to thank you, our shareholders, for supporting the advancement of medical research in
Australia through your investment in HM1.
Christopher Cuffe AO
Chairman
Paul Rayson
Chief Executive Officer
Sydney
29 August 2023
4
Hearts and Minds Investments Limited
Investment Committee Report
For the year ended 30 June 2023
Investment Committee Report
The Investment Committee of HM1, in conjunction with the Chief Investment Officer (CIO) Charlie Lanchester, is
responsible for implementing the Company’s investment strategy, including the selection of fund managers, managing
the investment portfolio and reviewing fund manager performance. The Company’s Investment Committee consists of
Lorraine Berends (Chair), David Wright, Christopher Cuffe, Matthew Grounds, Brett Paton and Paul Rayson. The
Investment Committee’s experience and qualifications are provided in the Directors’ Report.
HM1 Investment Strategy
HM1 invests in a concentrated portfolio of Australian and international securities based on the highest conviction ideas
from two groups of fund managers.
65% of the investment portfolio is held in up to 20 securities based on the highest conviction ideas of our Core
Fund Managers. The Core Fund Managers together with the CIO regularly monitor their recommendations.
35% of the investment portfolio is held in 10 to 15 securities based on the annual investment recommendations
of our Conference Fund Managers. HM1 generally allocates an equal weight investment to each of these
recommendations. These securities are expected to be held in the investment portfolio for a period of up to
12 months. After this period the securities are expected to be sold to invest in the recommendations of the
selected Conference Fund Managers who present at the next conference.
The Board’s view is that the investment strategy offers investors an opportunity to:
gain exposure to the highest conviction ideas, investment approach and expertise of each fund manager, a
number of whom are not otherwise readily accessible to retail investors;
benefit from having a portfolio that is not concentrated on the philosophy or investment style of just one fund
manager; and
access a concentrated portfolio of Australian and international securities which are expected to provide
attractive shareholder returns over the medium term (being five years or more).
HM1 aims to be fully invested subject to an appropriate cash buffer to meet tax liabilities, dividend payments, donation
payments and general expenses.
Company Performance
As a listed investment company, we use three key measures to evaluate the performance of HM1:
1.
2.
3.
Investment portfolio performance, which measures the growth of the investment portfolio on a pre-tax basis
and after the payment of all expenses, including the donation payments and provisions. An investment
benchmark, the MSCI World Index (AUD), is also measured before taxes. Our investment performance
compared to this benchmark is reported to shareholders on a monthly basis;
Net tangible asset (NTA) growth, which is a post-tax measure and represents the change in the value of the
Company’s assets less liabilities. The post-tax NTA of the Company is essentially the realisable value of the
Company at a point in time. The pre- and post-tax NTA per share of the Company is reported to shareholders
on a weekly basis; and
Total shareholder return, which measures the total return to shareholders from share price growth and
dividends paid.
5
Hearts and Minds Investments Limited
Investment Committee Report (continued)
For the year ended 30 June 2023
Each of these are set out below.
1.
Investment Portfolio Performance
Performance to 30 June 2023
1 year
3 year
Since
inception1
HM1 Investment Portfolio Performance
15.1%
-0.7% p.a.
8.8% p.a.
MSCI World Index (AUD)
20.8%
11.7% p.a.
10.4% p.a.
1. Inception 14 November 2018
The HM1 investment portfolio increased on a pre-tax basis by 15.1% for the year ended 30 June 2023 recovering some
of the losses of the prior year. Since the inception of the Company in November 2018, HM1 has generated a compound
annual pre-tax investment return of 8.8%. The current year’s investment performance was driven by a strong recovery
in the market value of the Core Portfolio, partially offset by realised losses from the previous year’s Conference
Portfolio.
The Core Portfolio recovered much of the unrealised losses recorded in 2022 driven by large share price gains in a
number of our Core Portfolio holdings, namely Zillow Group, Microsoft, Amazon, TSMC and Liberty Media Formula
One. We also sold or reduced a number of Core Portfolio holdings recording substantial realised gains in Mineral
Resources, Danaher, Alphabet and Microsoft. The major detractors to performance in the Core Portfolio were Just Eat
Takeaway, Spotify and Opthea. We appointed two new Core Fund Managers during the year, Munro Partners, and
Tribeca Investment Partners. We have invested in the recommendations of the new Core Fund Managers and we are
satisfied with the early progress.
As reported in the last Annual Report, the previous year’s Conference Portfolio performed very poorly and was sold
during the current financial year recording a significant loss. We have since made a number of changes to the selection
criteria for fund managers and the risk parameters for the Conference Portfolio construction. The current Conference
Portfolio is proving more resilient albeit has only recorded slight gains over the first seven months to 30 June 2023.
Major contributors to the Conference Portfolio to date are ASML, New Relic, Champion Iron and Carsales.
6
Hearts and Minds Investments Limited
Investment Committee Report (continued)
For the year ended 30 June 2023
2.
NTA Growth
HM1’s post-tax NTA increased 5.4% over the year from $641.1 million on 30 June 2022 to $675.5 million as of 30 June
2023. The following chart shows the components of the change in post-tax NTA over this period. The major increase
in post-tax NTA came from unrealised gains from the investment portfolio, partially offset by realised losses on the
Conference Portfolio and the tax benefit of the total net losses. HM1 also paid a fully franked dividend of 13.5 cents per
share amounting to a total dividend payment of $30.8 million. An amount of $3.8 million was reinvested by shareholders
in additional HM1 shares via the dividend reinvestment plan. The dividend reinvestment was satisfied by the acquisition
of 645,964 HM1 shares on market and the issue of 951,571 new HM1 shares. On a per share basis, HM1’s post-tax
NTA per share has increased from $2.81 on 30 June 2022 to $2.95 on 30 June 2023. The pre-tax NTA per share on
30 June 2023 was $2.90.
HM1 NTA Performance
3.
Total Shareholder Return
Total shareholder return measures the change in the HM1 share price plus dividends paid. HM1’s share price has
decreased from $2.50 at listing on 14 November 2018 to $2.26 on 30 June 2023. HM1 has paid three fully franked
dividends amounting to a total of 39 cents per share to shareholders. The notional value of a $10,000 investment in
HM1 shares from the date of listing, assuming the reinvestment of dividends would be $10,545 on 30 June 2023, an
increase of 5.5%. The HM1 share price of $2.26 on 30 June 2022 represented a 22% discount to the pre-tax NTA per
share of HM1 of $2.90.
Set out on the next page is a table of the investment portfolio holdings of HM1 on 30 June 2023 ranked by the market
value of HM1’s holdings.
7
Hearts and Minds Investments Limited
Investment Committee Report (continued)
For the year ended 30 June 2023
Investments at Fair Value on 30 June 2023
Company Name
Stock
Exchange
Fair Value
% of
Portfolio
Liberty Formula One
Nasdaq
$53,658,463
8.0%
Zillow Group, Inc. - C
Nasdaq
$38,464,286
5.8%
Mastercard Inc.
NYSE
$38,362,095
5.7%
Microsoft Corporation
Nasdaq
$38,326,080
5.7%
Intercontinental Exchange Inc.
NYSE
$35,634,454
5.3%
Block, Inc.
NYSE
$28,470,063
4.3%
ASML Holding N.V.
AMS
$21,706,684
3.2%
New Relic Inc.
NYSE
$21,603,842
3.2%
Carsales.com Ltd
ASX
$21,564,341
3.2%
BHP Group Ltd
ASX
$21,145,300
3.2%
Rokt Ltd
Unlisted
$20,912,365
3.1%
Champion Iron Ltd
ASX
$20,064,000
3.0%
Guzman Y Gomez Ltd
Unlisted
$20,000,000
3.0%
Nike Inc.
NYSE
$18,218,337
2.7%
Transurban Group
ASX
$18,097,500
2.7%
Eurofins Scientific
PAR
$17,137,476
2.6%
Darling Ingredients Inc.
NYSE
$16,272,959
2.4%
AMP Ltd
ASX
$15,820,000
2.4%
Regal Australia Long/Short Equity Fund
Unlisted
$15,465,021
2.3%
Brookfield Corporation
TSX
$15,161,241
2.3%
Ramsay Health Care
ASX
$12,946,700
1.9%
FDJ
PAR
$12,581,721
1.9%
Amazon.com Inc.
Nasdaq
$12,519,568
1.9%
Keywords Studio
LSE
$12,042,269
1.8%
NEXTDC
ASX
$11,322,000
1.7%
Constellation Energy Corporation
Nasdaq
$10,303,496
1.5%
Opthea Ltd
ASX
$8,859,783
1.3%
Taiwan Semiconductor Manufacturing Co. Ltd
NYSE
$8,480,672
1.3%
CTG Duty Free
HKE
$8,135,354
1.2%
Just Eat Takeaway.com N.V.
AMS
$6,893,100
1.0%
Domino Pizza Enterprises Ltd
ASX
$5,339,450
0.9%
Brookfield Asset Management Ltd
TSX
$3,674,731
0.5%
$59,246,589
9.0%
$668,429,940
100.00%
Cash and Cash Equivalents
Total Equity Securities
8
Hearts and Minds Investments Limited
Investment Committee Report (continued)
For the year ended 30 June 2023
Risk Analysis
The following information summarises the risk metrics of the security holdings in the HM1 investment portfolio on
30 June 2023 based on analysis prepared by Zenith Investment Partners. The analysis is a snapshot of the investment
portfolio structure and biases at that point in time and does not reflect any future biases within the portfolio.
Industry Exposure Biases
The investment portfolio is concentrated in a relatively small number of securities and sector exposure is clearly
weighted to certain industry sectors. Compared to the broad MSCI World Index ex Australia, the HM1 investment
portfolio exhibits positive biases to the IT and Internet Software and Services, Media, Real Estate Management,
Semiconductors, Steel, Diversified Metals and Gold sectors. The investment portfolio has negative (underweight)
biases to the Financial, Computers and Electronics, Food and Beverage, Retail, Health Care and Transportation
sectors. The chart below shows the differences in sector exposure of the investment portfolio compared to the broad
MSCI World Index ex Australia on 30 June 2023. Note that industry sectors where there is not a major difference in
exposure are not shown in the chart.
Active Style Biases
The chart below illustrates the style tilts exhibited in the HM1 investment portfolio based on the securities in the portfolio
on 30 June 2023.
9
Hearts and Minds Investments Limited
Investment Committee Report (continued)
For the year ended 30 June 2023
Active Style Biases (continued)
Consistent with HM1’s capital growth objective, the investment portfolio exhibits a strong factor bias to securities
categorised as growth securities with consequent higher volatility. Other significant style biases include a negative bias
to size (meaning a smaller companies bias than the benchmark), dividend yielding securities and value categorised
securities. Despite strong liquidity in the portfolio holdings, the negative size factor indicates a bias to mid capitalisation
securities compared to the comparative benchmark, the MSCI World Index (AUD). Eleven of the companies in the
investment portfolio have a market capitalisation of over US$50 billion. The smallest security is capitalised at A$270
million.
Risk Metrics
The following table provides a number of risk measures associated with the blend of securities that form the HM1
investment portfolio on 30 June 2023 compared to the MSCI World Index (AUD). As these risk measures are taken at
a specific point in time, these factors are not predictive of the risk characteristics of the HM1 investment portfolio going
forward. The portfolio displays a very high active share measure which indicates it is a concentrated high conviction
portfolio, is actively managed and does not closely track either the composition or performance of the MSCI World
Index (AUD). The investment portfolio carries a commensurate level of risk which is indicated by the low Sharpe ratio
and downside capture metrics.
HM1 Portfolio Risk Metrics (current portfolio since inception to 30 June 2023)
Portfolio Beta
1.34
Tracking Error
22.7%
Active Share
93.5%
Portfolio Volatility
27.7%
Correlation (with Benchmark)
0.59
Sharpe Ratio
-0.14
Upside Capture
89.7%
Downside Capture
176.4%
Lorraine Berends
Chair
Charlie Lanchester
Chief Investment Officer
10
Hearts and Minds Investments Limited
Investment Committee Report (continued)
For the year ended 30 June 2023
Our Fund Managers
We sincerely thank our participating fund managers that provide their time, expertise, and highest conviction investment
ideas on a pro bono basis. The notional value to HM1 of the investment management fees and performance fees
foregone during the financial year ended 30 June 2023 is equivalent to $9.7m.
Core Fund Managers
Seven Core Fund Managers each provide their highest conviction investment ideas which are reviewed regularly.
These securities represent 65% of the total investment portfolio.
Caledonia (Private) Investments Pty Limited is a global investment management firm with
offices in Sydney and New York. With over 25 years’ investment experience, Caledonia’s
goal is to achieve high absolute returns for their clients over a long-term time horizon. The
firm manages a long-short equity strategy with a focus on deep fundamental research and
high conviction long-term investing.
Cooper Investors Pty Limited is a specialist equities fund manager. Cooper Investors
commenced operations in 2001 and manages money for a range of clients, including large
pension and superannuation funds, religious institutions, Australian State Government
agencies, school endowments, charities, high net worth families and retail clients. Cooper
Investors is 100% owned by its employees. Cooper Investors seeks to invest in quality
companies with a strong value proposition.
Magellan Asset Management Limited is an Australian-based asset manager that is a
wholly-owned subsidiary of Magellan Financial Group Limited that was formed by Hamish
Douglass and Chris Mackay in Sydney in 2006. Magellan manages investments across its
global equities, global listed infrastructure and Australian equities strategies for retail, high
net worth and institutional investors.
Munro Partners is a global investment manager with a core focus on growth equities.
Established in 2016 by an award-winni
Share your feedback
Discover